Cargando…
Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use
Propylthiouracil (PTU) was introduced for clinical use in July 1947 for Graves' disease (GD) treatment. Over the 60 years that this medication has been used, reports of PTU-related liver failure and death have accumulated. On October 28, 2008, an expert panel evaluated PTU drug safety in childr...
Autores principales: | Rivkees, Scott A., Mattison, Donald R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777303/ https://www.ncbi.nlm.nih.gov/pubmed/19946400 http://dx.doi.org/10.1155/2009/132041 |
Ejemplares similares
-
63 Years and 715 Days to the “Boxed Warning”: Unmasking of the Propylthiouracil Problem
por: Rivkees, Scott A.
Publicado: (2010) -
Pediatric Graves’ disease: management in the post-propylthiouracil Era
por: Rivkees, Scott A
Publicado: (2014) -
Propylthiouracil Is Teratogenic in Murine Embryos
por: Benavides, Valeria C., et al.
Publicado: (2012) -
Churg-Strauss Syndrome following PTU Treatment
por: Quax, R. A. M., et al.
Publicado: (2009) -
Vedolizumab-Associated Hypereosinophilia and Hepatoxicity
por: De Marco, Davide, et al.
Publicado: (2022)